Article
Towards developing biomarkers for glioblastoma multiforme: a proteomics view
13 Aug 2014
Abstract excerpt
Glioblastoma multiforme (GBM) is one of the most aggressive and lethal forms of the primary brain tumors. With predominance of tumor heterogeneity and emergence of new subtypes, new approaches are needed to develop tissue-based markers for tumor typing or circulatory markers to serve as blood-based assays. Multi-omics data integration for GBM tissues would offer new insights on the molecular view of GBM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
